Vident Investment Advisory, LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2023$195,002
-65.1%
107,144
-2.7%
0.01%
-71.4%
Q4 2022$558,197
-42.4%
110,098
-43.6%
0.02%
-34.4%
Q3 2022$969,000
+20.5%
195,127
-9.7%
0.03%
+33.3%
Q2 2022$804,000
-28.9%
215,973
+7.1%
0.02%
-17.2%
Q1 2022$1,131,000
+10.4%
201,588
+19.7%
0.03%
+7.4%
Q4 2021$1,024,000
+7.6%
168,476
+72.3%
0.03%
-6.9%
Q3 2021$952,000
-36.4%
97,754
-6.7%
0.03%
-35.6%
Q2 2021$1,496,000104,7360.04%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
CVI Holdings, LLC 226,916$383,4880.76%
HARBOURVEST PARTNERS LLC 335,709$567,3480.19%
ALLEN HOLDING INC /NY 687,571$1,161,9950.16%
ARMISTICE CAPITAL, LLC 3,476,000$5,874,4400.09%
Clearwater Capital Advisors, LLC 394,599$666,8730.08%
SHEETS SMITH WEALTH MANAGEMENT 273,879$462,8560.07%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$162,9720.06%
WEALTH EFFECTS LLC 53,500$90,4150.04%
Virtus ETF Advisers LLC 34,461$58,2390.04%
FISHMAN JAY A LTD/MI 162,000$273,7800.04%
View complete list of IMMUNITYBIO INC shareholders